Physician

William Tony Mckenzie, M.D.

According to 2025 Medicare claims, William Mckenzie, M.D. (NPI: 1326060682) practices internal medicine in the Panama City-Panama City Beach, FL market, with the plurality of this provider's patient population coming from Bay, FL. This provider's primary affiliated billing organization is WILLIAM TONY MCKENZIE MD, PA (NPI: 1194873539) and primary practice location at 32401-2442.

Mckenzie's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,112 traditional Medicare patients, billed 7,350 HCPCS/CPT codes, and received $429,865 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,208 prescription claims across 278 beneficiaries totaling $682,711 in drug costs, led by Prolastin C (Alpha-1-Proteinase Inhibitor). DME data shows 16,457 claims. Open Payments data shows 131 records totaling $62,354. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments rose steadily, from $704,346 to $752,581.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,033	6,991	$421,814
2016	968	6,873	$398,924
2017	949	7,810	$397,466
2018	964	6,793	$357,352
2019	1,084	8,187	$454,415
2020	1,144	8,689	$467,803
2021	1,102	7,557	$412,044
2022	1,104	7,741	$418,116
2023	1,178	7,927	$432,687
2024	1,112	7,350	$429,865

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	375	2,205	$768,183
2016	379	2,230	$1,056,915
2017	394	2,446	$1,308,092
2018	383	2,217	$1,268,557
2019	417	2,212	$1,116,407
2020	401	2,140	$947,485
2021	344	1,815	$946,808
2022	279	1,331	$778,409
2023	275	1,181	$792,406
2024	278	1,208	$682,711

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	3,322	10,637	$1,139,489
2016	3,731	11,375	$903,212
2017	4,256	11,986	$763,402
2018	4,480	12,464	$829,410
2019	4,320	11,562	$977,313
2020	4,755	12,930	$1,467,244
2021	5,110	14,211	$1,417,300
2022	5,153	13,935	$1,307,782
2023	5,684	15,930	$1,362,031
2024	5,685	16,457	$1,417,953

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,052	2,512	$92
94729	Test to examine how well the lungs exchange gases	726	747	$41
94726	Test to determine lung volumes using sensors	716	737	$40
94060	Test to measure expiratory airflow and volume changes before and after medication administration	845	904	$28
96138	Administration of psychological or neuropsychological test by technician, first 30 minutes	298	302	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prolastin C	Alpha-1-Proteinase Inhibitor	23	630	$217,215
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	69	3,630	$72,383
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	50	2,880	$59,701
Spiriva Respimat	Tiotropium Bromide	38	2,220	$38,031
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	39	2,310	$36,391

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	92	559	$429,299
J7699	Noc drugs, inhalation solution administered through dme	N	22	58	$138,646
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	164	1,234	$96,799
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	187	1,038	$90,113
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	73	$73,974

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	131	$62,354	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for William Tony Mckenzie, M.D.?

Tedicare shows public-source Medicare data for William Tony Mckenzie, M.D. (NPI 1326060682), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William Tony Mckenzie, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to William Tony Mckenzie, M.D.?

William Tony Mckenzie, M.D. is linked to WILLIAM TONY MCKENZIE MD, PA (billing NPI 1194873539) in the available physician profile data.

Does William Tony Mckenzie, M.D. have Open Payments data?

William Tony Mckenzie, M.D. has 131 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.